RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Capital expenditures

CATALYST PHARMACEUTICALS, INC.CPRX

Market cap
$2.8B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-1+140.69%
Dec 31, 2023-0+696.55%
Dec 31, 2022-0-97.16%
Dec 31, 2021-1+8857.71%
Dec 31, 2020-0-41.15%
Dec 31, 2019-0-78.95%
Dec 31, 2018-0-4.21%
Dec 31, 2016-0+309.38%
Dec 31, 2015-0-59.07%
Dec 31, 2014-0-65.18%
Dec 31, 2013-0+6.08%
Dec 31, 2012-0+50.94%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)